Osmolex ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Vertical Pharmaceuticals, Llc. The primary component is Amantadine.
Product ID | 68025-021_ce2e1a99-33cb-84e4-e053-2a95a90a71e6 |
NDC | 68025-021 |
Product Type | Human Prescription Drug |
Proprietary Name | Osmolex ER |
Generic Name | Amantadine |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2022-05-05 |
Marketing End Date | 2023-06-30 |
Marketing Category | NDA / |
Application Number | NDA209410 |
Labeler Name | Vertical Pharmaceuticals, LLC |
Substance Name | AMANTADINE |
Active Ingredient Strength | 161 mg/1 |
Pharm Classes | Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA] |
NDC Exclude Flag | N |
Marketing Start Date | 2022-05-05 |
Marketing End Date | 2023-06-30 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
68025-021 | Osmolex ER | amantadine |
68025-074 | Osmolex ER | amantadine |
68025-075 | Osmolex ER | amantadine |
68025-076 | Osmolex ER | amantadine |
68025-077 | Osmolex ER | amantadine |
70482-075 | OSMOLEX ER | amantadine |
70482-076 | OSMOLEX ER | amantadine |
46708-246 | amantadine | amantadine |
46708-586 | Amantadine | Amantadine |
60687-422 | Amantadine | Amantadine |
62332-246 | amantadine | amantadine |
62332-586 | Amantadine | Amantadine |
70482-085 | GOCOVRI | AMANTADINE |
70482-170 | GOCOVRI | AMANTADINE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OSMOLEX ER 87639712 5770506 Live/Registered |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság 2017-10-10 |